相关实验视频
Updated: Jun 16, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
E2F1和E2F7通过转录激活和转录抑制MYBL2来分别调节胃癌细胞的增殖
Tianyi Wu1, Fengli Jiang2, Fan Wu1
1Department of Pathophysiology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
The Journal of biological chemistry
|November 29, 2024
概括
这项研究揭示了E2F1,E2F7和MYBL2在胃癌 (GC) 中被上调,影响患者的预后. 针对这些因素或它们的平衡为GC提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 胃癌 (GC) 是一种流行于消化道的恶性瘤,其分子驱动因素不明.
- 确定关键的分子参与者对于开发有效的向疗法至关重要.
研究的目的:
- 调查E2F1,E2F7和MYBL2在胃癌发病过程中的作用.
- 阐明在GC中针对这些因素的调控机制和治疗潜力.
主要方法:
- 对GC组织的生物信息分析.
- 基因表达分析和与患者预后的相关性.
- 在体外和体外细胞培养实验,包括基因淘汰和染色体免疫沉试验.
- 对PI3K/AKT信号通路和E2F7核细胞质分布的分析.
主要成果:
- 发现GC组织中E2F1,E2F7和MYBL2的上调,与较差的患者结果相关.
- E2F1和MYBL2的淘汰抑制了GC细胞的增殖和诱导细胞灭绝,而E2F7的淘汰促进了增殖.
- MYBL2作为E2F1 (激活) 和E2F7 (抑制) 的直接转录标,通过PI3K/AKT通路调解它们对细胞增殖的影响.
- 在GC细胞中观察到E2F7的核细胞质分布差异.
结论:
- MYBL2是E2F1和E2F7在调节胃癌细胞增殖中的关键下游效应因子.
- 准E2F1,E2F7,MYBL2,它们的表达平衡或E2F7定位为胃癌提供了新的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K

